The National Center for Hadrontherapy (CNAO) in Pavia, Italy, is the only facility in the country offering advanced hadrontherapy treatments specifically designed for radioresistant and inoperable tumors. Utilizing protons and carbon ions, CNAO provides an innovative approach to cancer treatment that enhances precision and minimizes damage to surrounding healthy tissues compared to traditional X-ray therapies. Established as part of the National Health Service since 2014, the center supports a range of conditions, including complex tumors of the brain, spinal cord, and pediatric cancers.

In addition to its therapeutic services, CNAO is committed to research and development, focusing on clinical and radiobiological studies aimed at improving cancer treatment methodologies. Patients can enjoy a comprehensive care pathway, encompassing initial assessments and follow-ups. CNAO not only addresses the urgent needs of patients with challenging malignancies but also champions ongoing scientific advancement in the battle against cancer, making it a key player in the global medical community.